Check out our video
Australis Pharma’s Innovative Drug Platform
Targeting Oncology
Australis Pharma is committed to bringing the next generation of pharmaceutical treatments to combat cancer. Our lead compound, AUS_001 highlights our novel preclinical anti-neoplastic agents with broad cancer efficacy, low side effects and the promise of oral administration.
Development pipeline
Balanced mix of chemical platform growth and lead candidate development.
We focus on efforts toward the development of our most promising compounds while further insuring our success by a steady stream of candidate research and IP generation. A major part of our effort goes into the R&D mechanistic studies to uncover new avenues of cancer treatment with focus not only on efficacy but also countering drug-resistance, minimizing side effects, and potentially improving patient treatment experiences.